Upstage Lung Cancer‘s Backstage@Upstage podcast recently featured Jill Feldman and Ivy Elkins as guests for an episode titled Biomarkers Benefit Lung Cancer Resisters.
Hosts Hildy Grossman and Jordan Rich spoke with Jill and Ivy about how their lung cancer diagnosis – along with the ability to detect a particular biomarker, EGFR – has affected the course of their lives. Biomarkers indicate alterations in your DNA that may drive a tumor. Using biomarker testing, it’s possible to refine diagnostic information to help select treatments to target directly that alteration.
Jill and Ivy channeled their experience as lung cancer survivors and advocates into creating the patient-centered organization, EGFR Resisters. This organization supports and notifies the EGFR-positive, lung cancer community about the latest information in diagnosis, research and treatment. Their vision is to support continued research to make lung cancer a manageable, chronic disease.
Listen to the episode:
Find out more about the podcast and listen to additional episodes here.